A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system
Martin W. LaFleur(Harvard University), Arlene H. Sharpe(Brigham and Women's Hospital)
Cited by 117
Related Papers
PD-1 and Its Ligands in Tolerance and Immunity
|Annual Review of Immunology|2008|5.3k
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|2.9k
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
|The Journal of Experimental Medicine|2009|2k
Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice
|Molecular and Cellular Biology|2000|1.2k